A de novo germline pathogenic BRCA1 variant identified following an osteosarcoma pangenomic molecular analysis.
Mouren A, Chansavang A, Hamzaoui N, Srikaran A, Laurent-Puig P, Marisa L, De Percin S, Lupo A, Larousserie F, Blons H, L'Haridon A, Burnichon N, Pasmant E, Tlemsani C.
Mouren A, et al.
Fam Cancer. 2024 May 19. doi: 10.1007/s10689-024-00393-0. Online ahead of print.
Fam Cancer. 2024.
PMID: 38763984